ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658142 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658142; 2) Community: the network communities that were significantly associated with the response to NSC 658142; 3) Molecule: the relationships between components within communities and NSC 658142; 4) MDR: the compounds that were significantly associated with the NSC 658142.

NSC Compound Enrichment Correlation
NSC 699667 Null 0.0228801759885691 0.43552214
NSC 710716 Null 0.0228801759885691 0.44251333
NSC 714379 Null 0.0228801759885691 0.34435277
NSC 720447 Null 0.0228801759885691 -0.22858688
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0228801759885691 0.22343676
NSC 733504 Everolimus 0.0228801759885691 -0.18470667
NSC 135037 Jatrophone 0.0238174255956144 0.53443075
NSC 156215 Streptovaricin complex, fraction b 0.0238174255956144 0.38478124
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0238174255956144 0.47765834
NSC 602617 Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 0.0238174255956144 0.53382583
Total:125  Current:70    [First] [Prev] [Next] [Last]